Baird Financial Group, Inc. - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 149 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,570,215
-56.0%
41,278
+5.5%
0.00%
-55.6%
Q2 2023$3,565,107
-11.2%
39,134
-35.7%
0.01%
-10.0%
Q1 2023$4,014,919
+196613.3%
60,869
+54.2%
0.01%
+100.0%
Q4 2022$2,041
-99.9%
39,477
+23.6%
0.01%
-16.7%
Q3 2022$2,182,000
+24.5%
31,944
-17.6%
0.01%
+20.0%
Q2 2022$1,753,000
-36.4%
38,772
-28.6%
0.01%
-28.6%
Q1 2022$2,757,000
+9.9%
54,266
+2.2%
0.01%
+16.7%
Q4 2021$2,509,000
+147.9%
53,075
+72.9%
0.01%
+100.0%
Q3 2021$1,012,000
-46.9%
30,698
+1.8%
0.00%
-40.0%
Q2 2021$1,906,000
+16.1%
30,156
-21.2%
0.01%0.0%
Q1 2021$1,642,000
+71.0%
38,277
+128.2%
0.01%
+66.7%
Q4 2020$960,000
+46.1%
16,777
-23.0%
0.00%
+50.0%
Q3 2020$657,000
-7.3%
21,778
+0.3%
0.00%
-33.3%
Q2 2020$709,000
+30.8%
21,703
+7.2%
0.00%
+50.0%
Q1 2020$542,000
-28.1%
20,248
-17.8%
0.00%
-33.3%
Q4 2019$754,000
-47.9%
24,623
-59.0%
0.00%
-50.0%
Q3 2019$1,447,000
-12.5%
60,082
-7.9%
0.01%0.0%
Q2 2019$1,653,00065,2290.01%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders